DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Jalan Transolutions (India) Limited — Shareholders meeting

NSE 1 hr ago·3 Sept 2026, 7:50 am

Jalan Transolu. India

Jalan Transolutions (India) Limited has announced that its Annual General Meeting (AGM) is scheduled for September 25, 2026. This is a standard corporate event where the company's board and shareholders will discuss financial results, appoint directors, and approve dividend payouts for the previous financial year.

For investors, this meeting is a key milestone as it provides a formal opportunity to review the company's performance and governance. The announcement itself does not carry immediate market-moving news, but it signals that the company is on track to complete its annual regulatory formalities.

Investors should watch for the outcome of the AGM, particularly any announcements regarding dividend declarations or future business strategies. These details will offer better insight into the company's financial health and management's outlook for the coming year.